×
About 5,760 results

ALLMedicine™ Alcohol Use Disorder Center

Research & Reviews  2,801 results

Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumato...
https://doi.org/10.1097/RHU.0000000000001731
Journal of Clinical Rheumatology : Practical Reports on R... Singh JA

Apr 12th, 2021 - To examine the incidence, time trends, and outcomes of alcohol use disorder (AUD) hospitalizations in people with gout, rheumatoid arthritis (RA), fibromyalgia, osteoarthritis, or low back pain (LBP). We used the US National Inpatient Sample data ...

Enhancement of Cue-Induced Reinstatement of Alcohol Seeking by Acute Total Sleep Restri...
https://doi.org/10.1016/j.pbb.2021.173188
Pharmacology, Biochemistry, and Behavior; Reeves-Darby JA, Berro LF et. al.

Apr 12th, 2021 - Clinical studies suggest that sleep impairment is a barrier to successful treatment in alcohol use disorder (AUD) patients, with sleep disruption associated with relapse to alcohol taking. To date, no preclinical study has evaluated the relationsh...

Psychological distress and alcohol use disorder during the COVID-19 era among middle- a...
https://doi.org/10.1016/j.jad.2021.03.085
Journal of Affective Disorders; Tsai J, Elbogen EB et. al.

Apr 11th, 2021 - This study examined how exposure to events during the Coronavirus Disease-19 (COVID-19) era is linked to symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), COVID-19 era-related stress (CS), alcohol use disorder (AUD),...

Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to ...
https://doi.org/10.1007/s40265-021-01509-x 10.1136/medethics-2017-104446 10.1001/jama.1973.03220320013004 10.2147/CLEP.S72906 10.1016/0890-6238(96)00057-3 10.1177/1756285615623934 10.1016/j.jaci.2004.10.023 10.1111/add.14429 10.1177/0269881112444324 10.1080/15622975.2018.1510185 10.1016/j.alcohol.2008.04.003 10.1111/j.1530-0277.1980.tb05628.x 10.1111/cns.12489 10.1097/GRF.0b013e31816fea3d 10.1016/S2214-109X(17)30021-9 10.1016/j.jad.2007.12.002 10.1176/appi.ajp.2018.18050632 10.1111/j.1479-828X.2008.00861.x 10.1007/s10995-010-0615-6 10.1001/jama.290.22.2996 10.1001/jamapediatrics.2017.1919 10.1097/ADM.0000000000000438 10.4103/0972-6748.132914 10.1136/jnnp.2007.128322 10.7895/ijadr.v2i2.89 10.1038/npp.2013.272 10.1038/nm1163 10.1001/archgenpsychiatry.2010.125 10.1097/01.ALC.0000108656.81563.05 10.1097/ADM.0b013e31816319fd 10.1016/0006-8993(93)90309-B 10.1523/JNEUROSCI.18-24-10663.1998 10.1186/s12916-018-1242-0 10.1001/archpsyc.1997.01830240090013 10.1111/j.1530-0277.1981.tb05354.x 10.1016/0005-7916(82)90050-7 10.1371/journal.pone.0087366 10.1192/bjp.161.1.84 10.15288/jsa.1988.49.219 10.1007/s40429-015-0076-5 10.1111/j.1360-0443.1995.tb03507.x 10.1080/10826080500391803 10.1111/j.1530-0277.2007.00418.x 10.1111/j.1360-0443.1993.tb03135.x 10.1177/1078390308325577 10.1080/10550881003684582 10.1111/j.1530-0277.2007.00356.x 10.1007/s10519-006-9081-8 10.1111/j.1465-3362.2012.00475.x 10.1093/alcalc/agp087 10.1097/HRP.0000000000000070 10.1176/appi.ajp.2017.1750101 10.1016/S0022-3476(84)80027-X 10.1016/j.genhosppsych.2015.02.001 10.1097/GRF.0000000000000417 10.2105/AJPH.2005.077222 10.1046/j.1360-0443.1999.941014996.x 10.1016/j.neulet.2004.10.037 10.1111/j.1530-0277.2001.tb02348.x 10.1016/0024-3205(83)90639-2 10.1371/journal.pone.0052812 10.1530/jrf.0.0390375 10.1016/j.ijgo.2003.10.001 10.1007/s40265-017-0762-9 10.1007/s40265-017-0763-8 10.1002/(SICI)1096-9926(199712)56:6<358::AID-TERA3>3.0.CO;2-S 10.1055/s-2007-994688 10.1016/S0140-6736(77)92534-X 10.1016/j.jsat.2007.10.007 10.1111/add.12551 10.1111/j.1360-0443.2006.01444.x 10.1097/ALN.0000000000000472 10.1016/S0140-6736(07)60464-4 10.1079/PNS2004385 10.1016/0024-3205(83)90355-7 10.1097/FBP.0b013e328345f72c 10.1093/alcalc/agh093 10.1111/j.1530-0277.1998.tb04295.x 10.1016/j.drugalcdep.2016.06.027
Drugs Kelty E, Terplan M et. al.

Apr 8th, 2021 - It is generally recommended that medications only be used in pregnancy where the potential harms to both the mother and foetus are outweighed by the potential benefits. Despite the known harms associated with alcohol consumption during pregnancy, ...

Alterations in connectivity of the bed nucleus of the stria terminalis during early abs...
https://doi.org/10.1111/acer.14596
Alcoholism, Clinical and Experimental Research; Flook EA, Feola B et. al.

Apr 8th, 2021 - For individuals with Alcohol Use Disorder (AUD), long-term recovery is difficult in part due to symptoms of anxiety that occur during early abstinence and can trigger relapse. Research in rodent models of AUD has identified the bed nucleus of the ...

see more →

Guidelines  4 results

Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: ...
https://doi.org/10.1007/s11739-018-1933-8
Internal and Emergency Medicine; Caputo F, Agabio R et. al.

Sep 6th, 2018 - The chronic use of alcohol can lead to the onset of an alcohol use disorder (AUD). About 50% of subjects with an AUD may develop alcohol withdrawal syndrome (AWS) when they reduce or discontinue their alcohol consumption and, in 3-5% of them, conv...

Pharmacological Treatment of Patients with Alcohol Use Disorder
https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9781615371969
Victor I. Reus

Dec 31st, 2017 - The goal of this guideline is to improve the quality of care and treatment outcomes for patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric Association 2013). The guideline focuses specifically on evidence-based pha.

Alcohol Intoxication and Cognition: Implications on Mechanisms and Therapeutic Strategies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029710/

Binge alcohol drinking is highly prevalent in young adults and results in 30% deaths per year in young males. Binge alcohol drinking or acute alcohol intoxication is a risk factor for developing alcohol use disorder (AUD). Three FDA approved drugs...

Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders
https://www.sciencedirect.com/science/article/abs/pii/S0165032719313229

Bipolar disorder (BD) frequently co-occurs with substance use disorders (SUDs), and both are associated with cognitive impairment. This study compares cognition between individuals with BD with and without current alcohol use disorder (AUD), cocai...

see more →

Clinicaltrials.gov  2,875 results

Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumato...
https://doi.org/10.1097/RHU.0000000000001731
Journal of Clinical Rheumatology : Practical Reports on R... Singh JA

Apr 12th, 2021 - To examine the incidence, time trends, and outcomes of alcohol use disorder (AUD) hospitalizations in people with gout, rheumatoid arthritis (RA), fibromyalgia, osteoarthritis, or low back pain (LBP). We used the US National Inpatient Sample data ...

Enhancement of Cue-Induced Reinstatement of Alcohol Seeking by Acute Total Sleep Restri...
https://doi.org/10.1016/j.pbb.2021.173188
Pharmacology, Biochemistry, and Behavior; Reeves-Darby JA, Berro LF et. al.

Apr 12th, 2021 - Clinical studies suggest that sleep impairment is a barrier to successful treatment in alcohol use disorder (AUD) patients, with sleep disruption associated with relapse to alcohol taking. To date, no preclinical study has evaluated the relationsh...

Psychological distress and alcohol use disorder during the COVID-19 era among middle- a...
https://doi.org/10.1016/j.jad.2021.03.085
Journal of Affective Disorders; Tsai J, Elbogen EB et. al.

Apr 11th, 2021 - This study examined how exposure to events during the Coronavirus Disease-19 (COVID-19) era is linked to symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), COVID-19 era-related stress (CS), alcohol use disorder (AUD),...

Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to ...
https://doi.org/10.1007/s40265-021-01509-x 10.1136/medethics-2017-104446 10.1001/jama.1973.03220320013004 10.2147/CLEP.S72906 10.1016/0890-6238(96)00057-3 10.1177/1756285615623934 10.1016/j.jaci.2004.10.023 10.1111/add.14429 10.1177/0269881112444324 10.1080/15622975.2018.1510185 10.1016/j.alcohol.2008.04.003 10.1111/j.1530-0277.1980.tb05628.x 10.1111/cns.12489 10.1097/GRF.0b013e31816fea3d 10.1016/S2214-109X(17)30021-9 10.1016/j.jad.2007.12.002 10.1176/appi.ajp.2018.18050632 10.1111/j.1479-828X.2008.00861.x 10.1007/s10995-010-0615-6 10.1001/jama.290.22.2996 10.1001/jamapediatrics.2017.1919 10.1097/ADM.0000000000000438 10.4103/0972-6748.132914 10.1136/jnnp.2007.128322 10.7895/ijadr.v2i2.89 10.1038/npp.2013.272 10.1038/nm1163 10.1001/archgenpsychiatry.2010.125 10.1097/01.ALC.0000108656.81563.05 10.1097/ADM.0b013e31816319fd 10.1016/0006-8993(93)90309-B 10.1523/JNEUROSCI.18-24-10663.1998 10.1186/s12916-018-1242-0 10.1001/archpsyc.1997.01830240090013 10.1111/j.1530-0277.1981.tb05354.x 10.1016/0005-7916(82)90050-7 10.1371/journal.pone.0087366 10.1192/bjp.161.1.84 10.15288/jsa.1988.49.219 10.1007/s40429-015-0076-5 10.1111/j.1360-0443.1995.tb03507.x 10.1080/10826080500391803 10.1111/j.1530-0277.2007.00418.x 10.1111/j.1360-0443.1993.tb03135.x 10.1177/1078390308325577 10.1080/10550881003684582 10.1111/j.1530-0277.2007.00356.x 10.1007/s10519-006-9081-8 10.1111/j.1465-3362.2012.00475.x 10.1093/alcalc/agp087 10.1097/HRP.0000000000000070 10.1176/appi.ajp.2017.1750101 10.1016/S0022-3476(84)80027-X 10.1016/j.genhosppsych.2015.02.001 10.1097/GRF.0000000000000417 10.2105/AJPH.2005.077222 10.1046/j.1360-0443.1999.941014996.x 10.1016/j.neulet.2004.10.037 10.1111/j.1530-0277.2001.tb02348.x 10.1016/0024-3205(83)90639-2 10.1371/journal.pone.0052812 10.1530/jrf.0.0390375 10.1016/j.ijgo.2003.10.001 10.1007/s40265-017-0762-9 10.1007/s40265-017-0763-8 10.1002/(SICI)1096-9926(199712)56:6<358::AID-TERA3>3.0.CO;2-S 10.1055/s-2007-994688 10.1016/S0140-6736(77)92534-X 10.1016/j.jsat.2007.10.007 10.1111/add.12551 10.1111/j.1360-0443.2006.01444.x 10.1097/ALN.0000000000000472 10.1016/S0140-6736(07)60464-4 10.1079/PNS2004385 10.1016/0024-3205(83)90355-7 10.1097/FBP.0b013e328345f72c 10.1093/alcalc/agh093 10.1111/j.1530-0277.1998.tb04295.x 10.1016/j.drugalcdep.2016.06.027
Drugs Kelty E, Terplan M et. al.

Apr 8th, 2021 - It is generally recommended that medications only be used in pregnancy where the potential harms to both the mother and foetus are outweighed by the potential benefits. Despite the known harms associated with alcohol consumption during pregnancy, ...

Alterations in connectivity of the bed nucleus of the stria terminalis during early abs...
https://doi.org/10.1111/acer.14596
Alcoholism, Clinical and Experimental Research; Flook EA, Feola B et. al.

Apr 8th, 2021 - For individuals with Alcohol Use Disorder (AUD), long-term recovery is difficult in part due to symptoms of anxiety that occur during early abstinence and can trigger relapse. Research in rodent models of AUD has identified the bed nucleus of the ...

see more →

News  69 results

Naltrexone Cuts Hospitalization, Deaths in Alcohol Use Disorder
https://www.medscape.com/viewarticle/944535

Jan 21st, 2021 - Naltrexone reduces the risk for hospitalization for alcohol use disorder (AUD), regardless of whether it is used alone or in conjunction with disulfiram or acamprosate, new research suggests. Investigators analyzed 10-year data on more than 125,00...

Fast Five Quiz: Alcohol Use Disorder
https://reference.medscape.com/viewarticle/936600_1

Sep 1st, 2020 - Alcohol use is the third-leading cause of preventable death in the United States. The World Health Organization (WHO) estimates that the harmful use of alcohol results in about 3 million deaths worldwide each year, which is 5.3% of all deaths. Alc...

Fast Five Quiz: Alcohol Use Disorder
https://reference.medscape.com/viewarticle/936600

Sep 1st, 2020 - Alcohol use is the third-leading cause of preventable death in the United States. The World Health Organization (WHO) estimates that the harmful use of alcohol results in about 3 million deaths worldwide each year, which is 5.3% of all deaths. Alc...

Reframing Alcohol Abuse as Treatable Cuts Stigma
https://www.staging.medscape.com/viewarticle/930047

May 5th, 2020 - As alcohol-related death and disease rates rise, framing alcohol use disorder as a treatable disease with neurobiologic underpinnings might help reduce the stigma that many patients endure, according to George F. Koob, PhD, director of the Nationa...

Reframing Alcohol Abuse as Treatable Cuts Stigma
https://www.medscape.com/viewarticle/930047

May 5th, 2020 - As alcohol-related death and disease rates rise, framing alcohol use disorder as a treatable disease with neurobiologic underpinnings might help reduce the stigma that many patients endure, according to George F. Koob, PhD, director of the Nationa...

see more →

Patient Education  11 results see all →